PE/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PECy7_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
  • 30-F11_PECy7_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103113 25 µg 70€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103114 100 µg 152€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Khare A, et al. 2016. Cell Rep. 15: 1700-1714. PubMed
  2. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  3. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  4. Garber C, et al. 2019. Nat Neurosci. 1.802777778. PubMed
  5. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  6. Wu JH, et al. 2020. EMBO Mol Med. 12:e10154. PubMed
  7. Rodriguez de la Fuente L, et al. 2021. STAR Protoc. 2:100841. PubMed
  8. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  9. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  10. Yang AC, et al. 2020. Nature. 583:425. PubMed
  11. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  12. Yagishita Y, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  13. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  14. Wagner G, et al. 2017. Sci Rep. 7:40881. PubMed
  15. Weeden C, et al. 2017. PLoS Biol. 10.1371/journal.pbio.2000731. PubMed
  16. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
  17. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  18. Smith NR, et al. 2017. Cell Mol Gastroenterol Hepatol. 0.395138889. PubMed
  19. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  20. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  21. Chang T, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006485. PubMed
  22. Kim SS, et al. 2022. Cancers (Basel). 14:. PubMed
  23. García-Prat L, et al. 2020. Nat Cell Biol. 22:1307. PubMed
  24. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  25. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  26. Helms EJ, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  27. Huck NA, et al. 2021. J Neurosci. 41:4349. PubMed
  28. Wu Q, et al. 2021. Cancer Commun (Lond). Online ahead of prin. PubMed
  29. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  30. Vila Ellis L, et al. 2020. Dev Cell. 617:52. PubMed
  31. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  32. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  33. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  34. Mansouri N, et al. 2019. JCI Insight. 4:e128060. PubMed
  35. Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed
  36. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  37. Manivasagam S, et al. 2022. J Immunol. 208:1341. PubMed
  38. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  39. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  40. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  41. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  42. White MPJ, et al. 2020. Front Immunol. 11:1830. PubMed
  43. Saito S, et al. 2020. Nutrients. 12:. PubMed
  44. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  45. Britschgi A, et al. 2017. Nature. 541:541-545. PubMed
  46. Valds-Mora F, et al. 2021. Cell Reports. 35(2):108945. PubMed
  47. DellOrso S, et al. 2021. STAR Protocols. 2(2):100451. PubMed
  48. Wang B, et al. 2017. EBioMedicine. 10.1016/j.ebiom.2017.03.041. PubMed
  49. Kaczmarek–Hájek K, et al. 2018. Elife. 7:e36217. PubMed
  50. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  51. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  52. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  53. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  54. Little DR, et al. 2021. Nat Commun. 12:2509. PubMed
  55. Bhopale VM, et al. 2021. J Appl Physiol (1985). 130:1604. PubMed
  56. Zheng L, et al. 2022. J Neuroinflammation. 19:128. PubMed
  57. Jiang YH, et al. 2020. J Mol Cell Cardiol. 138:115. PubMed
  58. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  59. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  60. Garber C, et al. 2018. Nat Immunol. 19:151. PubMed
  61. Campanario S, et al. 2021. Front Cell Dev Biol. 8:620409. PubMed
  62. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  63. Mizuochi C, et al. 2012. PLoS One. 7:e35763. PubMed
  64. Gigliotti J, et al. 2013. J Am Soc Nephrol. 24:1451. PubMed
  65. Wang B,et al. 2017. Cell Discov.. 10.1038/celldisc.2017.36. PubMed
  66. Solanas G, et al. 2017. Cell. 170:678. PubMed
  67. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  68. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  69. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  70. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  71. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  72. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  73. McGowan SE, et al. 2018. Am J Physiol Lung Cell Mol Physiol. 315:L102. PubMed
  74. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  75. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  76. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  77. Fix DK, et al. 2021. Aging Cell. 20:e13448. PubMed
  78. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  79. Zhu L, et al. 2021. Stem Cell Res Ther. 12:408. PubMed
  80. Allen S, et al. 2011. J Virol. 85:11448. PubMed
  81. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  82. Furuya Y, et al. 2015. PLoS Pathog. 11: 1005180. PubMed
  83. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  84. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  85. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  86. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  87. Onder L et al. 2017. Immunity. 47(1):80-92 . PubMed
  88. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  89. Kimbrough D, et al. 2018. J Mol Cell Cardiol. 119:51. PubMed
  90. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  91. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  92. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  93. Huang CH, et al. 2020. Adv Ther (Weinh). 3:. PubMed
  94. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  95. Okamura T, et al. 2021. Front Immunol. 12:669629. PubMed
  96. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  97. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  98. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  99. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  100. McCoy S 2015. Am J Physiol Lung Cell Mol Physiol. 309: L463-L474. PubMed
  101. Yen Y, et al. 2008. J Virol. 82:12312. PubMed
  102. Uribesalgo I, et al. 2019. EMBO Mol Med. 11:e9266. PubMed
  103. Son NH, et al. 2018. J Clin Invest. 128:4329. PubMed
  104. Ellegast JM, et al. 2022. Cancer Discov. 12:1760. PubMed
  105. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  106. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  107. Manco R, et al. 2021. Nat Commun. 12:3074. PubMed
  108. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  109. Berg AL, et al. 2022. Cancers (Basel). 14:. PubMed
  110. Ishii H, et al. 2012. Cell Death Dis. 9;3:e363. PubMed
  111. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  112. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  113. Kellish P, et al. 2019. J Clin Invest. 130:2279. PubMed
  114. Magri G et al. 2017. Immunity. 47(1):118-134 . PubMed
  115. Sela Y, et al. 2021. Elife. 10: . PubMed
  116. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  117. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  118. Pascual G, et al. 2021. Nature. 599:485. PubMed
  119. Kolodziejczyk AA, et al. 2020. Nat Med. 26:1899. PubMed
  120. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  121. Chu X, et al. 2021. Front Cell Dev Biol. 9:671841. PubMed
  122. Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed
  123. Wu X, et al. 2016. Sci Rep. 6:18685. PubMed
  124. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  125. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  126. van Gastel N, et al. 2020. Cell Metabolism. 32(3):391-403.e6. PubMed
  127. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  128. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  129. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  130. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  131. Jin L, et al. 2022. J Immunol Res. 2022:7222638. PubMed
  132. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  133. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  134. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  135. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  136. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  137. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  138. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  139. Li J, et al. 2020. Development. :. PubMed
  140. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  141. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  142. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  143. Wang W, et al. 2021. STAR Protocols. 2(3):100756. PubMed
  144. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  145. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  146. Mohammadpour H, et al. 2021. Cell Rep. 37:109883. PubMed
  147. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  148. Sung PS, et al. 2022. JCI Insight. :. PubMed
  149. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  150. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  151. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  152. Smith NR, et al. 2018. Cell Mol Gastroenterol Hepatol. 6:79. PubMed
  153. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  154. Nian Z, et al. 2021. Clin Cancer Res. 27:6026. PubMed
  155. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  156. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
  157. Ognjenovic NB, et al. 2020. Dev Cell. 55:544. PubMed
  158. Gu H, et al. 2021. Elife. 10:. PubMed
  159. Hendee K, et al. 2021. Aging (Albany NY). 13:7781. PubMed
  160. Issah Y, et al. 2021. Elife. 10:. PubMed
  161. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  162. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  163. Béchade C, et al. 2020. Glia. . PubMed
  164. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  165. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  166. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  167. Fan X, et al. 2020. Acta Physiol (Oxf). 230:e13475. PubMed
  168. Fang Y, et al. 2022. Development. 149:. PubMed
  169. Boyce M, et al. 2022. Cells. 11:. PubMed
  170. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  171. Sheng J, et al. 2021. eLife. 10:00. PubMed
  172. Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed
  173. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  174. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  175. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  176. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  177. Li Q, et al. 2022. J Biol Chem. :101753. PubMed
  178. Dong H, et al. 2022. Nat Metab. 4:90. PubMed
  179. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  180. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  181. Hussein M, et al. 2015. PLoS One. 10: 0135218. PubMed
  182. Gigliotti J, et al. 2015. J Am Soc Nephrol. 26: 2470 - 2481. PubMed
  183. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  184. Gerner-Mauro KN, et al. 2020. Proc Natl Acad Sci U S A. 117:12182. PubMed
  185. Kimmel JC, et al. 2021. Cell Reports. 35(4):109046. PubMed
  186. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  187. Ghosh S, et al. 2019. Commun Biol. 0.325. PubMed
  188. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  189. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  190. Wu H, et al. 2020. Cell. 180(1):107-121.e17.. PubMed
  191. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
  192. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  193. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  194. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  195. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  196. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
RRID
AB_312978 (BioLegend Cat. No. 103113)
AB_312979 (BioLegend Cat. No. 103114)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account